Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

Drug prices rise once again in 2020

Drug prices are on the move upward once again in 2020, according to new data from 3 Axis Advisors.

Thumbnail

Quality of care harmed after hospital acquisitions

Hospital acquisitions may have a negative impact on the quality of patient care, according to new findings published in the New England Journal of Medicine. The study results may help answer the question of how mergers and acquisitions impact patients and quality of care.

Thumbnail

Spending bill guts ACA taxes, medical device tax

President Trump signed the latest $1.4 trillion spending bills into law to fund the government and simultaneously gutted three taxes related to the Affordable Care Act: the health insurance tax, Cadillac tax and medical device tax.

Thumbnail

World’s most expensive drug could be free for some in lottery

Novartis may give away a new drug with a price tag above $2 million for free to some patients using a lottery-style program. The drug, Zolgensma, is a cure for a deadly inherited disease, spinal muscular atrophy, and the world’s most expensive drug.

Thumbnail

Physician salaries up 16.5% since 2015

The average salary for a physician was $363,924 in 2018, according to a new survey.

Thumbnail

Humana execs sell $38M in shares

Humana’s top executives offloaded a significant sum of shares in late December, shedding about 107,077 Humana shares worth $37.7 million, Louisville Business First reported.

Thumbnail

AI startup raises $45M in Series B funding

Paige, a New York-based healthcare startup focused on AI technologies, announced the completion of a Series B funding round worth $45 million.

Thumbnail

Cigna sells non-health business for $6.3B

Cigna, one of the nation’s largest health insurance providers, has agreed to sell its group disability and life insurance business to New York Life for a purchase price of $6.3 billion.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.